A 48-year-old woman on ICU has been treated for abdominal sepsis with piperacillin/tazobactam for 5 days. She is improving clinically. Blood cultures grew E. coli sensitive to amoxicillin, co-amoxiclav, and ciprofloxacin. When considering IV-to-oral antibiotic switch, which criteria should be met?